ATE411276T1 - Kristalle eines hydroxynorephedrinderivats - Google Patents
Kristalle eines hydroxynorephedrinderivatsInfo
- Publication number
- ATE411276T1 ATE411276T1 AT02765352T AT02765352T ATE411276T1 AT E411276 T1 ATE411276 T1 AT E411276T1 AT 02765352 T AT02765352 T AT 02765352T AT 02765352 T AT02765352 T AT 02765352T AT E411276 T1 ATE411276 T1 AT E411276T1
- Authority
- AT
- Austria
- Prior art keywords
- hydroxynorephedine
- crystals
- derivative
- methylethylüaminoüethylü
- dimethylphenoxyüacetate
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- 102000012367 Beta 3 adrenoceptor Human genes 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 206010036018 Pollakiuria Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 108040005346 beta3-adrenergic receptor activity proteins Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001277345 | 2001-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE411276T1 true ATE411276T1 (de) | 2008-10-15 |
Family
ID=19101883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02765352T ATE411276T1 (de) | 2001-09-13 | 2002-08-27 | Kristalle eines hydroxynorephedrinderivats |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7208520B2 (de) |
| EP (1) | EP1426355B1 (de) |
| JP (1) | JP4157036B2 (de) |
| KR (2) | KR100874952B1 (de) |
| CN (1) | CN1275936C (de) |
| AT (1) | ATE411276T1 (de) |
| AU (1) | AU2002330453B2 (de) |
| BR (1) | BR0212494A (de) |
| CA (1) | CA2458544C (de) |
| CO (1) | CO5560555A2 (de) |
| CY (1) | CY1109409T1 (de) |
| DE (1) | DE60229404D1 (de) |
| DK (1) | DK1426355T3 (de) |
| EA (1) | EA006022B1 (de) |
| EC (1) | ECSP045017A (de) |
| ES (1) | ES2314092T3 (de) |
| HR (1) | HRP20040250A2 (de) |
| HU (1) | HUP0401694A3 (de) |
| IL (2) | IL160681A0 (de) |
| MX (1) | MXPA04002449A (de) |
| NO (1) | NO328252B1 (de) |
| NZ (1) | NZ531602A (de) |
| PL (1) | PL206246B1 (de) |
| PT (1) | PT1426355E (de) |
| SI (1) | SI1426355T1 (de) |
| UA (1) | UA77000C2 (de) |
| WO (1) | WO2003024916A1 (de) |
| ZA (1) | ZA200401757B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| AU2004236596B2 (en) * | 2003-05-05 | 2010-03-11 | Kissei Pharmaceutical Co., Ltd. | Use of phenoxyacetic acid derivatives for treating hyperactive bladder |
| DE10351271A1 (de) * | 2003-10-31 | 2005-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung zur Behandlung der Stressinkontinenz und/oder Mischinkontinenz |
| EP1682183A2 (de) * | 2003-11-03 | 2006-07-26 | Boehringer Ingelheim International Gmbh | Pharmazeutische zusammensetzung enthaltend einen beta-3-adrenozeptor-agonisten und einem alpha antagonisten und/oder einen 5-alpha reduktase-hemmer |
| DE10352132A1 (de) * | 2003-11-04 | 2005-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten |
| WO2005092321A1 (ja) * | 2004-03-24 | 2005-10-06 | Kissei Pharmaceutical Co., Ltd. | 頻尿または尿失禁の予防または治療用医薬組成物 |
| JP4808613B2 (ja) * | 2004-03-24 | 2011-11-02 | キッセイ薬品工業株式会社 | 頻尿または尿失禁の予防または治療用医薬 |
| SI1612203T1 (sl) * | 2004-06-28 | 2007-12-31 | Gruenenthal Chemie | Kristalne oblike (-)-(1R,2R)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol hidroklorida |
| DE102004050952A1 (de) * | 2004-10-18 | 2006-04-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind |
| WO2006042679A1 (de) * | 2004-10-18 | 2006-04-27 | Boehringer Ingelheim International Gmbh | Verwendung eines beta-3-agonisten zur behandlung von beschwerden der prostata und des unteren urogenitaltrakts |
| CA2585037A1 (en) | 2004-10-26 | 2006-05-04 | Kissei Pharmaceutical Co., Ltd. | Synthesis of phenoxyacetic acid derivatives |
| TWI356699B (en) | 2004-11-10 | 2012-01-21 | Kissei Pharmaceutical | Agent for treating interstitial cystitis and agent |
| WO2006118087A1 (ja) * | 2005-04-26 | 2006-11-09 | Kissei Pharmaceutical Co., Ltd. | ヒドロキシノルエフェドリン誘導体塩酸塩・１／４水和物の結晶 |
| US7763654B2 (en) | 2005-04-26 | 2010-07-27 | Kissei Pharmaceutical Co., Ltd. | Crystal polymorph of hydroxynorephedrin derivative hydrochloride |
| EP1769792A1 (de) | 2005-09-30 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden |
| US8399410B2 (en) | 2007-08-06 | 2013-03-19 | Allergan, Inc. | Methods and devices for desmopressin drug delivery |
| SI3225250T1 (sl) | 2008-05-21 | 2019-11-29 | Ferring Bv | Orodisperzibilen dezmopresin za podaljšanje začetnega obdobja spanja, ki ga ne moti nokturija |
| US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
| US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| JP4005730B2 (ja) * | 1999-01-21 | 2007-11-14 | キッセイ薬品工業株式会社 | アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形 |
| JP4005729B2 (ja) * | 1999-01-21 | 2007-11-14 | キッセイ薬品工業株式会社 | アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形 |
| JP4005731B2 (ja) * | 1999-01-21 | 2007-11-14 | キッセイ薬品工業株式会社 | アミノエチルフェノキシ酢酸誘導体の結晶多形 |
-
2002
- 2002-08-27 ES ES02765352T patent/ES2314092T3/es not_active Expired - Lifetime
- 2002-08-27 SI SI200230775T patent/SI1426355T1/sl unknown
- 2002-08-27 WO PCT/JP2002/008596 patent/WO2003024916A1/ja not_active Ceased
- 2002-08-27 HR HR20040250A patent/HRP20040250A2/hr not_active Application Discontinuation
- 2002-08-27 JP JP2003528764A patent/JP4157036B2/ja not_active Expired - Fee Related
- 2002-08-27 IL IL16068102A patent/IL160681A0/xx unknown
- 2002-08-27 CA CA2458544A patent/CA2458544C/en not_active Expired - Fee Related
- 2002-08-27 HU HU0401694A patent/HUP0401694A3/hu unknown
- 2002-08-27 EA EA200400311A patent/EA006022B1/ru not_active IP Right Cessation
- 2002-08-27 AT AT02765352T patent/ATE411276T1/de active
- 2002-08-27 KR KR1020047003545A patent/KR100874952B1/ko not_active Expired - Fee Related
- 2002-08-27 BR BR0212494-7A patent/BR0212494A/pt not_active IP Right Cessation
- 2002-08-27 US US10/489,343 patent/US7208520B2/en not_active Expired - Fee Related
- 2002-08-27 PT PT02765352T patent/PT1426355E/pt unknown
- 2002-08-27 DE DE60229404T patent/DE60229404D1/de not_active Expired - Lifetime
- 2002-08-27 PL PL367874A patent/PL206246B1/pl not_active IP Right Cessation
- 2002-08-27 DK DK02765352T patent/DK1426355T3/da active
- 2002-08-27 EP EP02765352A patent/EP1426355B1/de not_active Expired - Lifetime
- 2002-08-27 CN CNB028175964A patent/CN1275936C/zh not_active Expired - Fee Related
- 2002-08-27 MX MXPA04002449A patent/MXPA04002449A/es active IP Right Grant
- 2002-08-27 AU AU2002330453A patent/AU2002330453B2/en not_active Ceased
- 2002-08-27 UA UA2004031852A patent/UA77000C2/uk unknown
- 2002-08-27 KR KR1020087026126A patent/KR20080098691A/ko not_active Ceased
-
2003
- 2003-08-27 NZ NZ531602A patent/NZ531602A/en not_active IP Right Cessation
-
2004
- 2004-03-02 IL IL160681A patent/IL160681A/en not_active IP Right Cessation
- 2004-03-03 ZA ZA200401757A patent/ZA200401757B/en unknown
- 2004-03-12 EC EC2004005017A patent/ECSP045017A/es unknown
- 2004-03-12 CO CO04022925A patent/CO5560555A2/es not_active Application Discontinuation
- 2004-03-12 NO NO20041060A patent/NO328252B1/no not_active IP Right Cessation
-
2009
- 2009-01-14 CY CY20091100027T patent/CY1109409T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60229404D1 (de) | Kristalle eines hydroxynorephedrinderivats | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| NO20051209L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme | |
| SE0104334D0 (sv) | Therapeutic agents | |
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| SE0201544D0 (sv) | Novel compounds and thier use | |
| BRPI0406883A (pt) | Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
| DK2017276T3 (da) | Phenylcarboxamid-forbindelser til behandling af smerte | |
| WO2004041802A8 (en) | 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders | |
| CA2315235A1 (en) | Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same | |
| WO2000056315A8 (en) | Treatment of pain | |
| NO20052699L (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
| CA2438509A1 (en) | Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria | |
| IL177626A0 (en) | Pharmaceutical compositions for treating sleep apnoea | |
| SE0104333D0 (sv) | Therapeutic agents | |
| NO20050903L (no) | Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser | |
| BRPI0513549A (pt) | composições farmacêuticas para o tratamento de leishmaniose | |
| ATE295845T1 (de) | Prucaloprid-n-oxid | |
| MXPA01009461A (es) | Tratamiento de osteoartritis. | |
| WO2005035500A3 (en) | Therapeutic agents useful for treating pain | |
| BR0116724A (pt) | Composto, método de tratamento de um distúrbio neurológico ou de uma doença neurodegenerativa, método de tratamento de dor, composição farmacêutica, uso de um composto, e, processos para a preparação e para a sìntese de um composto | |
| SE0302666D0 (sv) | Novel Compounds | |
| DE60117472D1 (de) | Pharmazeutische zusammensetzung zur behandlung von fettleibigkeit | |
| ITTO20040343A1 (it) | Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1426355 Country of ref document: EP |